Pharmaceuticals

Global Benchtop Bioreactors Industry Trends and Market Forecast 2026–2030

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the benchtop bioreactors market from 2026–2035 with trusted insights from The Business Research Company

How is the Benchtop Bioreactors Market size predicted to change over the forecast window of 2026–2035?

The benchtop bioreactors market size has seen significant growth in recent years. It is anticipated to expand from $1.08 billion in 2025 to $1.19 billion in 2026, at a compound annual growth rate (CAGR) of 10.2%. This market’s historical growth can be ascribed to increased investment in life sciences research, the expansion of academic and research institutes, a reliance on small-scale fermentation systems, a rise in pharmaceutical R&D activities, and the growing demand for controlled laboratory environments.

The market for benchtop bioreactors is projected to experience swift expansion over the coming years, anticipated to reach $1.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This anticipated growth is driven by several factors, including the increasing development of biologics and biosimilars, the embrace of automated and continuous bioreactor systems, a heightened emphasis on personalized medicine research, greater collaboration with cros, and progress in bioprocessing technologies. Key trends expected during this forecast period involve the increasing integration of benchtop bioreactors into research and development activities, a surge in demand for single-use and modular bioreactor setups, a stronger focus on enhancing process efficiency and yield, the broader scope of cell culture and microbial fermentation investigations, and the growing application of benchtop bioreactors in training and academic research.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27220&type=smp

Which Drivers Are Contributing To The Expansion Of The Benchtop Bioreactors Market?

The growing use of gene therapies is anticipated to drive the expansion of the benchtop bioreactors market moving forward. Gene therapy is defined as a medical approach centered on altering or substituting flawed genes to manage or avert illnesses. The heightened demand for gene therapy arises from progress in genetic sequencing and diagnostic tools, which facilitate the accurate identification of disease-causing genes for targeted interventions. Benchtop bioreactors play a crucial role in speeding up gene therapies by providing precise control and effective production of gene-modified cells. These devices facilitate swift research and small-scale production, thereby enhancing process velocity and dependability. For example, in December 2024, reports from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific body, indicated that the Food and Drug Administration (FDA) sanctioned six gene therapy products in 2023, an increase from five approvals recorded in 2022. Thus, the increasing uptake of gene therapies is a key factor propelling the benchtop bioreactors market’s growth.

What Segment Categories Are Covered In The Benchtop Bioreactors Market?

The benchtop bioreactors market covered in this report is segmented –

1) By Type: Swing-Style Bioreactors, Stirred-Tank Bioreactors, Wave-Mixed Bioreactors, Airlift Bioreactors, Bubble Column Bioreactors

2) By Control Type: Automated Bioreactors, Manual Bioreactors, Continuous Bioreactors, Batch Bioreactors

3) By Material: Stainless Steel, Glass, Plastic, Composite Materials

4) By Application: Research And Development, Process Development, Bioproduction, Quality Control, Training And Education

5) By End User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Food And Beverage Industry

Subsegments:

1) By Swing-Style Bioreactors: Single-Use Swing Bioreactors, Multi-Use Swing Bioreactors, Compact Swing Bioreactors, Automated Swing Bioreactors

2) By Stirred-Tank Bioreactors: Single-Use Stirred-Tank Bioreactors, Glass Stirred-Tank Bioreactors, Stainless-Steel Stirred-Tank Bioreactors, Modular Stirred-Tank Bioreactors, Automated Stirred-Tank Bioreactors

3) By Wave-Mixed Bioreactors: Single-Use Wave-Mixed Bioreactors, Dual-Motion Wave-Mixed Bioreactors, Automated Wave-Mixed Bioreactors, Compact Wave-Mixed Bioreactors

4) By Airlift Bioreactors: Internal Loop Airlift Bioreactors, External Loop Airlift Bioreactors, Single-Use Airlift Bioreactors

5) By Bubble Column Bioreactors: Vertical Bubble Column Bioreactors, Single-Use Bubble Column Bioreactors, Gas-Lift Bubble Column Bioreactors, Automated Bubble Column Bioreactors

How Are Emerging Trends Affecting The Progression Of The Benchtop Bioreactors Market?

Major companies in the benchtop bioreactors market are concentrating on creating advanced solutions, such as benchtop fermenters, to improve precise control and expandability for research and small-scale production. Benchtop fermenters are compact, laboratory-scale bioreactors specifically designed for the controlled cultivation of microorganisms or cells, supporting both research and limited production. For instance, in September 2024, VFL Sciences Private Limited, an India-based biotechnology equipment manufacturer, introduced its GreatFlo range of benchtop fermenters or bioreactors. This versatile and modular product line is designed for simple scale-up and consistent reproducibility in fermentation and cell culture applications. These fermenters enable seamless parallel operation with flexible expansion options from 2 to 16 vessels, each offering a working volume of 200-500 ml. They come equipped with Peltier-controlled heating and cooling, exhaust condensers, and software compliant with 21 CFR Part 11, ensuring precise regulation of agitation, pH, dissolved oxygen, and individual gas mixing.

Which Key Market Players Are Investing In Expansion And Innovation Within The Benchtop Bioreactors Market?

Major companies operating in the benchtop bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Sartorius AG, Eppendorf AG, Solaris Biotech Solutions, IKA-Werke GmbH And Co. KG, GPC Bio USA, Praj HiPurity Systems Limited., PBS Biotech Inc., Bioengineering AG, Broadley-James Ltd., Infors HT, Solida Biotech, Bbi-biotech GmbH, Applikon Biotechnology B.V., Labfirst Scientific Instruments Co. Ltd, Pharsol Ltd., Uma Pharmatech Machinery

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/benchtop-bioreactors-global-market-report

Which Regions Are Poised For Strategic Growth In The Benchtop Bioreactors Market?

North America was the largest region in the benchtop bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benchtop bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Benchtop Bioreactors Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27220&type=smp

Browse Through More Reports Similar to the Global Benchtop Bioreactors Market 2026, By The Business Research Company

Hydraulic Fracturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hydraulic-fracturing-global-market-report

Hydraulic Excavator Market Report 2026

https://www.thebusinessresearchcompany.com/report/hydraulic-excavator-global-market-report

Hydraulic Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hydraulic-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795